UC Santa Cruz Awarded Grant to Fund Human Genetic Variation Map
News Jul 23, 2015
Earlier this year, the institute received a commitment of up to $1 million from the Simons Foundation to begin work on the map. With that funding, "we've been experimenting with pilot regions of the genome and evaluating a variety of methods," Genomics Institute researcher and project co-principal investigator Benedict Paten said in a statement.
With the money from the Keck Foundation, "the next steps will be to take it from a prototype to a full-scale genome reference that we can release to the community," he added.
To build the map, the Genomics Institute said its scientists have been collaborating with the Global Alliance for Genomics and Health, which includes more than 300 institutions sharing their genomic and clinical data.
It is expected that a new, comprehensive map will "replace the current assortment of isolated, incompatible databases of human genetic variation with a single, fundamental representation formalized as a very large mathematical graph," the institute stated. "This mathematical graph-based structure will augment the existing human reference genome with all common human variations, providing a means to name, identify, and analyze variations precisely and reproducibly."
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE